SC Filed 2022-03-04 Event — SEC 0001140361-22-008013 →

VIKING GLOBAL INVESTORS LP → Ginkgo Bioworks Holdings, Inc. DNABW

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

19 filings by this filer

18 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

10,871 shares short · 0.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $639K

Point72 Asset Mgmt

Other 13D/G Filings on Ginkgo Bioworks Holdings, Inc.

Filed	Form	Filer	Stake	Shares
2025-02-14	SCHEDULE	Shetty Reshma P.	9.50%	4,716,084	view →
2023-01-25	SC	Kelly Jason R	—	—	view →
2022-10-05	SC	Shetty Reshma P.	—	—	view →
2021-10-01	SC	VIKING GLOBAL INVESTORS LP	—	—	view →

Other Filings by VIKING GLOBAL INVESTORS LP

Filed	Form	Issuer	Stake	Shares
2026-04-02	SCHEDULE 13D/A	BridgeBio Pharma, Inc. BBIO	6.10%	11,842,434	view →
2025-07-01	SCHEDULE	BridgeBio Pharma, Inc. BBIO	9.80%	18,602,920	view →
2025-01-31	SCHEDULE	BridgeBio Pharma, Inc. BBIO	11.70%	22,055,375	view →
2023-11-07	SC	Cazoo Group Ltd	—	—	view →
2023-09-22	SC	Cazoo Group Ltd	—	—	view →
2023-07-20	SC	BridgeBio Pharma, Inc. BBIO	—	—	view →
2023-04-27	SC	Cazoo Group Ltd	—	—	view →
2023-02-27	SC	Cazoo Group Ltd	—	—	view →
2021-10-01	SC	Ginkgo Bioworks Holdings, Inc. DNABW	—	—	view →
2019-07-12	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-07-12	SC	Axovant Gene Therapies Ltd.	—	—	view →
2019-07-12	SC	Urovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Myovant Sciences Ltd.	—	—	view →
2019-03-19	SC	Axovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Axovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Urovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2018-01-16	SC	Arbutus Biopharma Corp ABUS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →